Skip to content
thestock.space

On 6 Nov 2026, IEL was priced at ₹5.45, or 45.4× trailing earnings, against an industry P/E of 22.1×, and the shares are 37% below their 52-week high. Its ROCE of 0.7% is the lowest among the 7 largest Specialty Chemicals peers, and sales and net profit fell 54% and 57% a year over 3 years. The company has almost no debt. It is a small-cap company with a market cap of ₹71 Cr, ranked 157th of 204 Specialty Chemicals companies by market cap; the shares fell 32% over the past year.

As of 6 Nov 2026Prices are delayed about 15 minutes; fundamentals are from the quarter ended Jun 2026.How we calculate this

past year
Open
₹5.68
Day high
₹5.68
Day low
₹5.32
Prev. close
₹5.50
Volume
14.7K

Health check

6 to check
  • ReturnsBehind

    −32.3% over a year, better than 0 of 7 peers.

  • Price tagPricier

    P/E 45.4 vs industry 22.1.

  • GrowthShrinking

    Sales −54.3%, profit −57.3% a year over 3 years.

  • ProfitabilityWeak

    ROCE 0.7% vs peer median 24.4%.

  • Balance sheetStretched

    Practically debt-free, Piotroski 3 of 9.

  • Red flags4 to check

    Return on equity is low at 0.4%.

Compared with 7 industry peers. Computed from reported figures. Educational, not a recommendation.

Specialty Chemicals

203 listed peers. Screen the industry

Small cap

₹71 Cr, #157 of 204 in its industry by size.

Market sensitivity

Measuring against the NIFTY 50…

Key metrics

Last 12 months to Jun 2026: sales ₹1 Cr · profit ₹1 Cr
Market cap
₹71 Cr
Small cap
P/E
45.4
Industry 22.1
Price to book
1.58
Peers 13.33
Dividend yield
0.00%
ROE
0.4%
Peers 23.0%
ROCE
0.7%
Peers 24.4%
Debt to equity
0.02
Debt ₹0.90 Cr
EPS (TTM)
₹0.12
OPM (TTM)
153.0%
Net margin 101.6%
Sales growth
n/a
Year-ago quarter not reported
Profit growth
n/a
Year-ago quarter not reported
Price to sales
48.35
EV/EBITDA 48.9

Strengths and risks

Strengths

  • Practically debt-free.
  • Net margin of 101.6%.

Risks to check

  • Return on equity is low at 0.4%.
  • P/E of 45.4 against an industry P/E of 22.1.
  • 37% below its 52-week high.
  • Interest coverage of only −0.3×.

Derived automatically from reported figures. Not a recommendation.

About IEL

IEL Limited manufactures, trades, and markets chemicals, pharmaceuticals, and drug intermediates. The company also engages in solar and renewable energy; infrastructure and industrial support; trading and business operations; and project development businesses. In addition, it provides warehousing, leasing, renting, hire-purchase, market support, and distributors, as well as information technology consultancy or related products, and health or medical…

Headquarters
Ahmedabad
Employees
1
Sector
Basic Materials
ISIN
INE056E01024
Website
iellimited.com

Price range

52 weeks

₹4.50₹8.65

Today

₹5.32₹5.68
Avg volume (3M)
2.3 L
1-year return
minus 32.3%
From 52-week high
minus 37.0%

Peers · Specialty Chemicals

Capital-heavy industry columns

Compare with peersScreen the whole industry
Company
ASIANPAINTAsian Paints2,546.00plus 0.88%2,44,02550.535.024.4%18.9%0.211.1%plus 1.5%
SOLARINDSSolar Industries India18,608.00plus 0.48%1,68,38474.464.129.5%27.8%0.2212.4%plus 35.9%
PIDILITINDPidilite Industries1,579.00plus 1.63%1,60,82760.044.428.5%23.5%0.037.4%plus 6.8%
LINDEINDIALinde India6,859.00plus 8.73%58,496118.464.216.3%31.5%0.23–plus 5.4%
BERGEPAINTBerger Paints India478.35minus 5.28%55,77645.429.420.6%15.3%0.154.2%minus 6.0%
FLUOROCHEMGujarat Fluorochemicals4,665.50minus 0.94%51,25175.944.09.6%24.1%0.26−4.5%plus 28.0%
ACUTAASAcutaas Chemicals3,786.60plus 0.42%31,00170.964.127.7%39.4%0.0129.4%plus 105.6%
INDXTRAIEL5.45minus 0.91%7145.4–0.7%153.0%0.02−54.3%minus 32.3%
Median of 7 peers–0.48%58,49670.944.424.4%24.1%0.215.8%6.8%

Quarterly results

Consolidated, ₹ crore
SalesSelect a row below to chart it
₹ CrJun 25Sep 25Dec 25Mar 26Jun 26
––0.60.40.5
––0.100.1
−0.8−0.10.40.40.4
––81.6%99.0%76.5%
0.1000.30.4
0000.10
00000
−0.7−0.10.50.70.8
−0.2%−0.9%1.5%10.1%25.2%
−0.7−0.10.50.60.6
-0.06-0.010.040.040.04

Profit & loss

Yearly, ₹ crore
Sales CAGR 3Y
−54.3%
Profit CAGR 3Y
−57.3%
EPS CAGR 3Y
−35.7%
ROE
0.4%
Net profitSelect a row below to chart it
₹ CrMar 2023Mar 2024Mar 2025Mar 2026
10.217.36.21
–+69.6%minus 64.3%minus 84.3%
8.616.95.51
1.60.40.6−0
15.8%2.2%10.1%−2.5%
0.8000.4
0000.1
0.1000
0–−0−0
2.40.30.60.3
−0.4%25.8%25.8%29.0%
2.40.30.40.2
–minus 89.1%+68.0%minus 57.2%
0.530.060.030.01

EPS is shown as reported. The EPS CAGR above adjusts earlier years for the 10:1 on Sept 2023 split/bonus; dilution from new shares is not adjusted.

Forecast

Your assumptions, not a prediction

Balance sheet

At each financial year end, ₹ crore
Total assetsSelect a row below to chart it
₹ CrMar 2023Mar 2024Mar 2025Mar 2026
3.33.31313
−2.4−2.131.832
––0.50.6
2.62.51.61.5
3.53.846.947.1
0.20.2012
–––12
0.90.425.20.1
2.43.221.723
3.53.846.947.1

Cash flow

Yearly, ₹ crore
Cash from operationsSelect a row below to chart it
₹ CrMar 2023Mar 2024Mar 2025Mar 2026
0.9−0.52.1−0
−0.2−0−21−25
−0−043.7−0.1
0.7−0.524.8−25.1
−0.2−0−0−12
0.7−0.52.1−12.1

Shareholding pattern

This company is listed only on BSE, so there’s no NSE category split. See Major shareholders below for the named holders.

Major shareholders

BSE filing

Filings & events

News

No recent news coverage found.

My notes

Private to you